BlackBarn Capital Partners’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.9M | Buy |
3,446,570
+564,916
| +20% | +$4.57M | 1.6% | 2 |
|
|
2025
Q1 | $24.1M | Buy |
2,881,654
+31,654
| +1% | +$265K | 1.54% | 4 |
|
|
2024
Q4 | $22.6M | Buy |
2,850,000
+438,388
| +18% | +$3.47M | 1.24% | 5 |
|
|
2024
Q3 | $20.1M | Buy |
2,411,612
+411,612
| +21% | +$3.42M | 2.64% | 3 |
|
|
2024
Q2 | $12.7M | Buy |
2,000,000
+586,703
| +42% | +$3.73M | 1.13% | 4 |
|
|
2024
Q1 | $8.56M | Buy |
+1,413,297
| New | +$8.56M | 4.84% | 10 |
|